Anrukinzumab
Product Specifications
CAS Number
910649-32-0
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.983
Bioactivity
Anrukinzumab (IMA-638) is a humanized monoclonal antibody that specifically targets and neutralizes interleukin-13 (IL-13) . Anrukinzumab has demonstrated significant anti-inflammatory effects in validated non-human primate models of disease, supporting its ongoing research for the treatment of ulcerative colitis (UC) and asthma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A179027-1MG 1 mg
N-Acetyl-S-(2-hydroxy-1-phenylethyl)-L-cysteine-d3 + N-Acetyl-S-(2-hydroxy-2-phenylethyl)-L-cysteine-d3 (Mixture)
Sign In for Pricing
View Details 
LC422457 20 µg
Rho GTPase activating protein 24 (ARHGAP24) (NM_001025616) Human Over-expression Lysate
Sign In for Pricing
View Details 